ARCHIVES

Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.

This article is from The Cancer Letter archive.

Vol. 30 No. 26 | June 25, 2004

Download PDF Visit The Full Archive

Related Articles

Guest Editorial “Gizmo Idolatry” and Marketing Da Vinci’s Radical Robot

September 26, 2014

Rogers Subcommittee Rewrite Cancer Control Definition, Adds $45 Million Over Three Years

April 21, 1978

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

Spending Bill Could Give 15% Raise To NIH; Gimmicks Complicate Picture, Veto Looms

November 5, 1999

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program

September 5, 1975